Nanolive – Cooperation Profile

What We Offer to Horizon Europe Consortia

1. New Approach Methodologies (NAMs) / Alternative to Animal Testing

• A proven technology to generate human-relevant, functional cellular readouts.

• Non-invasive measurement of mitochondrial dynamics, cytotoxicity, cell death pathways, and metabolic stress.

• AI-driven quantitative endpoints aligned with regulatory expectations for mechanism-based NAMs.

2. Advanced Tools for ATMPs

• Real-time monitoring of stem cells, CAR-T, immune cells, and other ATMPs without labels.

• Characterization of cell state, activation, viability, proliferation, and quality attributes.

• Enabling technology for CoEs on ATMPs and next-generation manufacturing workflows.

3. Regulatory Science & Translational Development

• High-quality datasets that support validation, standardization, and regulatory acceptance of new testing modalities.

• Expertise in designing robust analytical pipelines for drug discovery and safety assessment.

• Strong alignment with calls requiring quantitative, reproducible, patient-relevant data.

4. AI-driven Biomedical Research Tools

• Automated cellular segmentation, lineage tracking, and phenotype classification.

• Integrations with data science workflows for computational biology and multi-omics pipelines.

• Experience collaborating with pharma partners (e.g., Sanofi) on predictive safety and efficacy models.